Literature DB >> 8877968

Prognosis of malignant mammary tumor in 53 cats.

T Ito1, T Kadosawa, M Mochizuki, S Matsunaga, R Nishimura, N Sasaki.   

Abstract

Medical records of fifty-three cats diagnosed as malignant mammary tumor from 1982 to 1993 were reviewed. The mean age of the cats at diagnosis was 11.1 years, and Japanese domestic and Siamese breeds were predominant. Survival rates after 1 and 2 years of diagnosis were 31.8% and 17.7%, respectively, suggesting poor prognosis of this malignancy. The survival time was significantly associated with tumor size or WHO clinical stage, but not with breed, age, or gender. Twenty-nine cats with pulmonary metastasis died within 5 months following metastatic detection. Postoperative prognosis was significantly related to the tumor size at surgery, but not with type of surgery and adjuvant chemotherapy using cyclophosphamide and/or vincristine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877968     DOI: 10.1292/jvms.58.723

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  9 in total

1.  Feline mammary adenocarcinoma: tumor size as a prognostic indicator.

Authors:  Jodi R Viste; Sherry L Myers; Baljit Singh; Elemir Simko
Journal:  Can Vet J       Date:  2002-01       Impact factor: 1.008

2.  The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells in vitro.

Authors:  A Deveci Ozkan; G Guney Eskiler; O Turna; N Kazan; E Sozen Kucukkara; A Baykal; K Sonmez
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

3.  Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions.

Authors:  Sara Santos; Estela Bastos; Cláudia S Baptista; Daniela Sá; Christophe Caloustian; Henrique Guedes-Pinto; Fátima Gärtner; Ivo G Gut; Raquel Chaves
Journal:  Int J Mol Sci       Date:  2012-03-02       Impact factor: 6.208

4.  Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.

Authors:  Yohan Truchot; Elie Dagher; Jérôme Abadie; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2021-01-22

5.  Comparative value of clinical, cytological, and histopathological features in feline mammary gland tumors; an experimental model for the study of human breast cancer.

Authors:  Radmehr Shafiee; Javad Javanbakht; Nahid Atyabi; Alimohammad Bahrami; Danial Kheradmand; Reyhaneh Safaei; Farshid Khadivar; Ehsan Hosseini
Journal:  Diagn Pathol       Date:  2013-08-13       Impact factor: 2.644

6.  Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma.

Authors:  Masaki Michishita; Aya Ohtsuka; Rei Nakahira; Tsuyoshi Tajima; Takayuki Nakagawa; Nobuo Sasaki; Toshiro Arai; Kimimasa Takahashi
Journal:  J Vet Med Sci       Date:  2015-11-28       Impact factor: 1.267

7.  Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas.

Authors:  Florian Chocteau; Marie-Mélanie Boulay; Fanny Besnard; Germain Valeau; Delphine Loussouarn; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2019-11-07

8.  Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.

Authors:  Elie Dagher; Violette Royer; Paul Buchet; Jérôme Abadie; Delphine Loussouarn; Mario Campone; Frédérique Nguyen
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

9.  Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma.

Authors:  Suzanne Rosen; Becky K Brisson; Amy C Durham; Clare M Munroe; Conor J McNeill; Darko Stefanovski; Karin U Sørenmo; Susan W Volk
Journal:  PLoS One       Date:  2020-08-10       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.